TreeWAS – Variant ID: rs10508881

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I20-I25 Ischaemic heart diseases	1.000	0.000	0.000
I25 Chronic ischaemic heart disease	1.000	0.000	0.000
I20 Angina pectoris	0.999	0.001	0.000
I20.9 Angina pectoris, unspecified	0.999	0.001	0.000
I25.1 Atherosclerotic heart disease	0.997	0.003	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.972	0.028	0.000
I21 Acute myocardial infarction	0.920	0.080	0.000
I24 Other acute ischaemic heart diseases	0.912	0.088	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.893	0.107	0.000
I25.5 Ischaemic cardiomyopathy	0.884	0.116	0.000
I20.1 Angina pectoris with documented spasm	0.876	0.124	0.000
I21.9 Acute myocardial infarction, unspecified	0.872	0.128	0.000
I24.8 Other forms of acute ischaemic heart disease	0.864	0.136	0.000
I22 Subsequent myocardial infarction	0.848	0.152	0.000
I20.8 Other forms of angina pectoris	0.826	0.174	0.000
I25.2 Old myocardial infarction	0.793	0.207	0.000
I25.6 Silent myocardial ischaemia	0.791	0.209	0.000
I25.3 Aneurysm of heart	0.770	0.230	0.000
I22.8 Subsequent myocardial infarction of other sites	0.748	0.252	0.000
I24.1 Dressler's syndrome	0.732	0.268	0.000
I21.3 Acute transmural myocardial infarction of unspecified site	0.699	0.301	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.690	0.310	0.000
I21.X Presumed acute myicardial infaction (unconfirmed)	0.659	0.341	0.000
I23 Certain current complications following acute myocardial infarction	0.652	0.348	0.000
I22.0 Subsequent myocardial infarction of anterior wall	0.638	0.362	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.633	0.367	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.592	0.408	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.530	0.470	0.000
I25.0 Atherosclerotic cardiovascular disease, so described	0.516	0.484	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.513	0.487	0.000
I25.4 Coronary artery aneurysm	0.512	0.488	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.473	0.527	0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.467	0.532	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.467	0.532	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.467	0.532	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.467	0.532	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.467	0.532	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.467	0.532	0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.440	0.559	0.000
I23.8 Other current complications following acute myocardial infarction	0.435	0.565	0.000
I21.4 Acute subendocardial myocardial infarction	0.215	0.785	0.000
I20.0 Unstable angina	0.209	0.791	0.000
M48.06 Spinal stenosis (Lumbar region)	0.172	0.828	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.165	0.835	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.156	0.844	0.000
C85.1 B-cell lymphoma, unspecified	0.153	0.847	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.146	0.854	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.130	0.870	0.000
C85.0 Lymphosarcoma	0.112	0.888	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.095	0.905	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.064	0.936	0.000
C88 Malignant immunoproliferative diseases	0.058	0.941	0.000
C92 Myeloid leukaemia	0.056	0.944	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.053	0.947	0.000
C92.1 Chronic myeloid leukaemia	0.053	0.947	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.052	0.948	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.051	0.949	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.049	0.951	0.000
C83.0 Small cell (diffuse)	0.048	0.952	0.000
C86 Other specified types of T/NK-cell lymphoma	0.047	0.953	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.046	0.954	0.000
C94 Other leukaemias of specified cell type	0.045	0.955	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.044	0.956	0.000
C92.7 Other myeloid leukaemia	0.044	0.956	0.000
C91 Lymphoid leukaemia	0.043	0.957	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.042	0.958	0.000
C88.7 Other malignant immunoproliferative diseases	0.042	0.958	0.000
C88.3 Immunoproliferative small intestinal disease	0.042	0.958	0.000
C88.2 Gamma heavy chain disease	0.042	0.958	0.000
C88.1 Alpha heavy chain disease	0.042	0.958	0.000
C92.9 Myeloid leukaemia, unspecified	0.041	0.958	0.000
C92.2 Subacute myeloid leukaemia	0.041	0.959	0.000
C83.7 Burkitt's tumour	0.041	0.959	0.000
C93 Monocytic leukaemia	0.041	0.959	0.000
C82.0 Small cleaved cell, follicular	0.041	0.959	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.040	0.960	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.040	0.960	0.000
C92.3 Myeloid sarcoma	0.040	0.960	0.000
C92.4 Acute promyelocytic leukaemia	0.040	0.960	0.000
C95 Leukaemia of unspecified cell type	0.040	0.960	0.000
C92.5 Acute myelomonocytic leukaemia	0.040	0.960	0.000
C83.5 Lymphoblastic (diffuse)	0.040	0.960	0.000
C83.1 Small cleaved cell (diffuse)	0.039	0.961	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.039	0.961	0.000
C83.6 Undifferentiated (diffuse)	0.038	0.962	0.000
C83.4 Immunoblastic (diffuse)	0.038	0.962	0.000
C83.2 Mixed small and large cell (diffuse)	0.038	0.962	0.000
C91.1 Chronic lymphocytic leukaemia	0.038	0.962	0.000
C82.6 Cutaneous follicle centre lymphoma	0.037	0.963	0.000
C82.5 Diffuse follicle centre lymphoma	0.037	0.963	0.000
Z63.4 Disappearance and death of family member	0.000	0.963	0.037
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.036	0.964	0.000
C82.4 Follicular lymphoma grade IIIb	0.036	0.964	0.000
C82.3 Follicular lymphoma grade IIIa	0.036	0.964	0.000
C82.2 Large cell, follicular	0.035	0.965	0.000
Z63 Other problems related to primary support group, including family circumstances	0.000	0.965	0.035
C82.1 Mixed small cleaved and large cell, follicular	0.034	0.965	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.034	0.965	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.034	0.965	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.034	0.966	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.034	0.966	0.000
C86.4 Blastic NK-cell lymphoma	0.034	0.966	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.034	0.966	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.034	0.966	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.034	0.966	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.034	0.966	0.000
Z63.0 Problems in relationship with spouse or partner	0.000	0.966	0.034
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.033	0.967	0.000
C96.8 Histiocytic sarcoma	0.033	0.967	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.033	0.967	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.033	0.967	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.033	0.967	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.033	0.967	0.000
C96.3 True histiocytic lymphoma	0.033	0.967	0.000
C96.2 Malignant mast cell tumour	0.033	0.967	0.000
C96.1 Malignant histiocytosis	0.033	0.967	0.000
C96.0 Letterer-Siwe disease	0.033	0.967	0.000
C94.7 Other specified leukaemias	0.032	0.967	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.032	0.967	0.000
C94.5 Acute myelofibrosis	0.032	0.967	0.000
C94.3 Mast cell leukaemia	0.032	0.967	0.000
C94.2 Acute megakaryoblastic leukaemia	0.032	0.967	0.000
C94.1 Chronic erythraemia	0.032	0.967	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.032	0.967	0.000
C94.4 Acute panmyelosis	0.032	0.968	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.031	0.969	0.000
C91.7 Other lymphoid leukaemia	0.031	0.969	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.031	0.969	0.000
C91.3 Prolymphocytic leukaemia	0.031	0.969	0.000
C91.2 Subacute lymphocytic leukaemia	0.031	0.969	0.000
C81 Hodgkin's disease	0.031	0.969	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.029	0.970	0.000
C93.9 Monocytic leukaemia, unspecified	0.029	0.970	0.000
C93.7 Other monocytic leukaemia	0.029	0.970	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.029	0.970	0.000
C93.2 Subacute monocytic leukaemia	0.029	0.970	0.000
C93.0 Acute monocytic leukaemia	0.029	0.970	0.000
C95.7 Other leukaemia of unspecified cell type	0.029	0.971	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.029	0.971	0.000
C91.5 Adult T-cell leukaemia	0.029	0.971	0.000
Z63.6 Dependent relative needing care at home	0.000	0.971	0.029
C91.9 Lymphoid leukaemia, unspecified	0.028	0.972	0.000
C95.0 Acute leukaemia of unspecified cell type	0.028	0.972	0.000
C91.0 Acute lymphoblastic leukaemia	0.028	0.972	0.000
Z63.7 Other stressful life events affecting family and household	0.000	0.972	0.028
C91.4 Hairy-cell leukaemia	0.027	0.973	0.000
C83.3 Large cell (diffuse)	0.027	0.973	0.000
C02.9 Tongue, unspecified	0.025	0.975	0.000
Z63.9 Problem related to primary support group, unspecified	0.000	0.975	0.025
Z63.3 Absence of family member	0.000	0.975	0.025
Z63.2 Inadequate family support	0.000	0.975	0.025
Z63.1 Problems in relationship with parents and in-laws	0.000	0.975	0.025
C84.8 Cutaneous T-cell lymphoma, unspecified	0.025	0.975	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.024	0.975	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.024	0.975	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.024	0.975	0.000
C84.3 Lymphoepithelioid lymphoma	0.024	0.975	0.000
C84.2 T-zone lymphoma	0.024	0.975	0.000
C84.1 Sezary's diease	0.024	0.975	0.000
C93.1 Chronic monocytic leukaemia	0.024	0.976	0.000
C95.9 Leukaemia, unspecified	0.024	0.976	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.024	0.976	0.000
C92.0 Acute myeloid leukaemia	0.024	0.976	0.000
Z63.8 Other specified problems related to primary support group	0.000	0.976	0.024
Z63.5 Disruption of family by separation and divorce	0.000	0.976	0.023
C84.4 Peripheral T-cell lymphoma	0.022	0.978	0.000
C81.0 Lymphocytic predominance	0.022	0.978	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.022	0.978	0.000
C81.3 Lymphocytic depletion	0.022	0.978	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.022	0.978	0.000
C84.5 Other and unspecified T-cell lymphomas	0.022	0.978	0.000
C81.7 Other Hodgkin's disease	0.020	0.979	0.000
C81.2 Mixed cellularity	0.020	0.980	0.000
C02.4 Lingual tonsil	0.020	0.980	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.020	0.980	0.000
C02.2 Ventral surface of tongue	0.020	0.980	0.000
M48.0 Spinal stenosis	0.020	0.980	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.000	0.980	0.020
C84.0 Mycosis fungoides	0.019	0.981	0.000
C81.9 Hodgkin's disease, unspecified	0.019	0.981	0.000
Z58 Problems related to physical environment	0.000	0.981	0.019
C06 Malignant neoplasm of other and unspecified parts of mouth	0.019	0.981	0.000
Z58.1 Exposure to air pollution	0.000	0.982	0.018
C14.0 Pharynx, unspecified	0.018	0.982	0.000
C81.1 Nodular sclerosis	0.018	0.982	0.000
C01 Malignant neoplasm of base of tongue	0.018	0.982	0.000
C12 Malignant neoplasm of pyriform sinus	0.018	0.982	0.000
C09 Malignant neoplasm of tonsil	0.018	0.982	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.017	0.982	0.000
C02.0 Dorsal surface of tongue	0.017	0.982	0.000
C03 Malignant neoplasm of gum	0.017	0.983	0.000
C00 Malignant neoplasm of lip	0.017	0.983	0.000
C02.8 Overlapping lesion of tongue	0.017	0.983	0.000
C13 Malignant neoplasm of hypopharynx	0.017	0.983	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.017	0.983	0.000
Z57 Occupational exposure to risk-factors	0.000	0.983	0.017
C10 Malignant neoplasm of oropharynx	0.016	0.983	0.000
Z57.3 Occupational exposure to other air contaminants	0.000	0.984	0.016
C04 Malignant neoplasm of floor of mouth	0.016	0.984	0.000
C02.1 Border of tongue	0.016	0.984	0.000
Z61 Problems related to negative life events in childhood	0.000	0.984	0.016
C06.0 Cheek mucosa	0.016	0.984	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.015	0.985	0.000
Z58.5 Exposure to other pollution	0.000	0.985	0.015
C11 Malignant neoplasm of nasopharynx	0.015	0.985	0.000
C06.9 Mouth, unspecified	0.015	0.985	0.000
M48.04 Spinal stenosis (Thoracic region)	0.015	0.985	0.000
C03.1 Lower gum	0.014	0.985	0.000
C14.2 Waldeyer's ring	0.014	0.985	0.000
Z65 Problems related to other psychosocial circumstances	0.000	0.985	0.014
M48.03 Spinal stenosis (Cervicothoracic region)	0.014	0.986	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.014	0.986	0.000
Z62 Other problems related to upbringing	0.000	0.986	0.014
Z55 Problems related to education and literacy	0.000	0.986	0.014
Z58.8 Other problems related to physical environment	0.000	0.986	0.014
Z64 Problems related to certain psychosocial circumstances	0.000	0.986	0.014
F17.2 Dependence syndrome	0.014	0.986	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.014	0.986	0.000
C00.0 External upper lip	0.014	0.986	0.000
C13.0 Postcricoid region	0.014	0.986	0.000
C06.2 Retromolar area	0.014	0.986	0.000
C09.9 Tonsil, unspecified	0.014	0.986	0.000
Z57.2 Occupational exposure to dust	0.000	0.986	0.014
Z58.9 Problem related to physical environment, unspecified	0.000	0.986	0.014
Z58.6 Inadequate drinking-water supply	0.000	0.986	0.014
Z58.4 Exposure to radiation	0.000	0.986	0.014
Z58.3 Exposure to soil pollution	0.000	0.986	0.014
Z58.2 Exposure to water pollution	0.000	0.986	0.014
Z58.0 Exposure to noise	0.000	0.986	0.014
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.014	0.986	0.000
C06.1 Vestibule of mouth	0.014	0.986	0.000
C00.1 External lower lip	0.013	0.987	0.000
C09.0 Tonsillar fossa	0.013	0.987	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.013	0.987	0.000
M48.09 Spinal stenosis (Site unspecified)	0.013	0.987	0.000
Z56 Problems related to employment and unemployment	0.000	0.987	0.013
C09.1 Tonsillar pillar (anterior) (posterior)	0.013	0.987	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.013	0.987	0.000
C04.0 Anterior floor of mouth	0.013	0.987	0.000
C05 Malignant neoplasm of palate	0.013	0.987	0.000
C09.8 Overlapping lesion of tonsil	0.013	0.987	0.000
C90.3 Solitary plasmacytoma	0.013	0.987	0.000
C03.0 Upper gum	0.013	0.987	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.013	0.987	0.000
C00.8 Overlapping lesion of lip	0.013	0.987	0.000
C00.6 Commissure of lip	0.013	0.987	0.000
C00.5 Lip, unspecified, inner aspect	0.013	0.987	0.000
C00.4 Lower lip, inner aspect	0.013	0.987	0.000
C00.3 Upper lip, inner aspect	0.013	0.987	0.000
C00.2 External lip, unspecified	0.013	0.987	0.000
C10.9 Oropharynx, unspecified	0.013	0.987	0.000
C13.8 Overlapping lesion of hypopharynx	0.012	0.987	0.000
C13.2 Posterior wall of hypopharynx	0.012	0.987	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.012	0.987	0.000
C03.9 Gum, unspecified	0.012	0.988	0.000
C07 Malignant neoplasm of parotid gland	0.012	0.988	0.000
Z61.6 Problems related to alleged physical abuse of child	0.000	0.988	0.012
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group	0.000	0.988	0.012
C00.9 Lip, unspecified	0.012	0.988	0.000
C13.9 Hypopharynx, unspecified	0.012	0.988	0.000
Z57.9 Occupational exposure to unspecified risk-factor	0.000	0.988	0.012
Z57.7 Occupational exposure to vibration	0.000	0.988	0.012
Z57.6 Occupational exposure to extreme temperature	0.000	0.988	0.012
Z57.4 Occupational exposure to toxic agents in agriculture	0.000	0.988	0.012
Z57.1 Occupational exposure to radiation	0.000	0.988	0.012
Z57.0 Occupational exposure to noise	0.000	0.988	0.012
C10.8 Overlapping lesion of oropharynx	0.012	0.988	0.000
C10.4 Branchial cleft	0.012	0.988	0.000
C10.3 Posterior wall of oropharynx	0.012	0.988	0.000
C10.2 Lateral wall of oropharynx	0.012	0.988	0.000
C10.1 Anterior surface of epiglottis	0.012	0.988	0.000
C10.0 Vallecula	0.012	0.988	0.000
C04.8 Overlapping lesion of floor of mouth	0.012	0.988	0.000
C04.1 Lateral floor of mouth	0.012	0.988	0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.000	0.988	0.012
Z61.9 Negative life events in childhood, unspecified	0.000	0.988	0.011
Z61.8 Other negative life events in childhood	0.000	0.988	0.011
Z61.7 Personal frightening experience in childhood	0.000	0.988	0.011
Z61.3 Events resulting in loss of self-esteem in childhood	0.000	0.988	0.011
Z61.2 Altered pattern of family relationships in childhood	0.000	0.988	0.011
Z61.1 Removal from home in childhood	0.000	0.988	0.011
Z61.0 Loss of love relationship in childhood	0.000	0.988	0.011
M48.00 Spinal stenosis (Multiple sites in spine)	0.011	0.989	0.000
C04.9 Floor of mouth, unspecified	0.011	0.989	0.000
Z58.7 Exposure to tobacco smoke	0.000	0.989	0.011
C11.8 Overlapping lesion of nasopharynx	0.011	0.989	0.000
C11.3 Anterior wall of nasopharynx	0.011	0.989	0.000
C11.2 Lateral wall of nasopharynx	0.011	0.989	0.000
C11.1 Posterior wall of nasopharynx	0.011	0.989	0.000
C11.0 Superior wall of nasopharynx	0.011	0.989	0.000
Z65.9 Problem related to unspecified psychosocial circumstances	0.000	0.989	0.011
C90.1 Plasma cell leukaemia	0.011	0.989	0.000
Z56.3 Stressful work schedule	0.000	0.989	0.011
Z65.5 Exposure to disaster, war and other hostilities	0.000	0.989	0.010
Z65.4 Victim of crime and terrorism	0.000	0.989	0.010
Z65.3 Problems related to other legal circumstances	0.000	0.989	0.010
Z65.2 Problems related to release from prison	0.000	0.989	0.010
Z65.1 Imprisonment and other incarceration	0.000	0.989	0.010
Z65.0 Conviction in civil and criminal proceedings without imprisonment	0.000	0.989	0.010
Z55.9 Problems relating to education and literacy, unspecified	0.000	0.989	0.010
Z55.8 Other problems relating to education and literacy	0.000	0.989	0.010
Z55.4 Educational maladjustment and discord with teachers and classmates	0.000	0.989	0.010
Z55.3 Underachievement in school	0.000	0.989	0.010
Z55.2 Failed examinations	0.000	0.989	0.010
Z55.1 Schooling unavailable and unattainable	0.000	0.989	0.010
Z55.0 Illiteracy and low-level literacy	0.000	0.989	0.010
Z62.9 Problem related to upbringing, unspecified	0.000	0.989	0.010
Z62.8 Other specified problems related to upbringing	0.000	0.989	0.010
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing	0.000	0.989	0.010
Z62.5 Other problems related to neglect in upbringing	0.000	0.989	0.010
Z62.4 Emotional neglect of child	0.000	0.989	0.010
Z62.3 Hostility towards and scapegoating of child	0.000	0.989	0.010
Z62.2 Institutional upbringing	0.000	0.989	0.010
Z62.1 Parental overprotection	0.000	0.989	0.010
Z62.0 Inadequate parental supervision and control	0.000	0.989	0.010
Z64.4 Discord with counsellors	0.000	0.989	0.010
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful	0.000	0.989	0.010
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful	0.000	0.989	0.010
Z64.1 Problems related to multiparity	0.000	0.989	0.010
Z57.8 Occupational exposure to other risk-factors	0.000	0.990	0.010
Z64.0 Problems related to unwanted pregnancy	0.000	0.990	0.010
Z65.8 Other specified problems related to psychosocial circumstances	0.000	0.990	0.010
C11.9 Nasopharynx, unspecified	0.010	0.990	0.000
Z56.7 Other and unspecified problems related to employment	0.000	0.990	0.010
Z56.5 Uncongenial work	0.000	0.990	0.010
Z56.4 Discord with boss and workmates	0.000	0.990	0.010
Z56.2 Threat of job loss	0.000	0.990	0.010
Z56.1 Change of job	0.000	0.990	0.010
C08.8 Overlapping lesion of major salivary glands	0.009	0.990	0.000
C08.1 Sublingual gland	0.009	0.990	0.000
C05.8 Overlapping lesion of palate	0.009	0.990	0.000
C05.2 Uvula	0.009	0.990	0.000
C05.1 Soft palate	0.009	0.990	0.000
C05.9 Palate, unspecified	0.009	0.991	0.000
S72.20 Subtrochanteric fracture (closed)	0.009	0.991	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.009	0.991	0.000
Z60 Problems related to social environment	0.000	0.991	0.009
C08.0 Submandibular gland	0.008	0.991	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.008	0.992	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.992	0.000
T39.0 Salicylates	0.008	0.992	0.000
S72.30 Fracture of shaft of femur (closed)	0.008	0.992	0.000
Z56.6 Other physical and mental strain related to work	0.000	0.992	0.008
S72.2 Subtrochanteric fracture	0.008	0.992	0.000
C08.9 Major salivary gland, unspecified	0.008	0.992	0.000
C90.2 Plasmacytoma, extramedullary	0.007	0.992	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.992	0.000
Z59 Problems related to housing and economic circumstances	0.000	0.992	0.008
Z60.8 Other problems related to social environment	0.000	0.992	0.008
Z56.0 Unemployment, unspecified	0.000	0.992	0.007
S72.3 Fracture of shaft of femur	0.007	0.993	0.000
S72 Fracture of femur	0.007	0.993	0.000
S70 Superficial injury of hip and thigh	0.007	0.993	0.000
C05.0 Hard palate	0.006	0.993	0.001
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
S01.9 Open wound of head, part unspecified	0.007	0.993	0.000
Z60.5 Target of perceived adverse discrimination and persecution	0.000	0.993	0.006
Z60.4 Social exclusion and rejection	0.000	0.993	0.006
Z60.3 Acculturation difficulty	0.000	0.993	0.006
Z60.1 Atypical parenting situation	0.000	0.993	0.006
Z60.0 Problems of adjustment to life-cycle transitions	0.000	0.993	0.006
S70.0 Contusion of hip	0.006	0.993	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.994	0.006
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
Z59.2 Discord with neighbours, lodgers and landlord	0.000	0.994	0.006
S72.21 Subtrochanteric fracture (open)	0.006	0.994	0.000
S72.1 Pertrochanteric fracture	0.006	0.994	0.000
Z59.7 Insufficient social insurance and welfare support	0.000	0.994	0.006
Z59.6 Low income	0.000	0.994	0.006
Z59.5 Extreme poverty	0.000	0.994	0.006
Z59.3 Problems related to living in residential institution	0.000	0.994	0.006
H90.2 Conductive hearing loss, unspecified	0.000	0.994	0.006
S72.8 Fractures of other parts of femur	0.006	0.994	0.000
S70-S79 Injuries to the hip and thigh	0.006	0.994	0.000
S72.9 Fracture of femur, part unspecified	0.006	0.994	0.000
N81.2 Incomplete uterovaginal prolapse	0.000	0.994	0.006
S70.8 Other superficial injuries of hip and thigh	0.005	0.995	0.000
S72.7 Multiple fractures of femur	0.005	0.995	0.000
C18.5 Splenic flexure	0.005	0.995	0.000
I08.0 Disorders of both mitral and aortic valves	0.000	0.995	0.005
Z59.4 Lack of adequate food	0.000	0.995	0.005
Z59.0 Homelessness	0.000	0.995	0.005
Z59.8 Other problems relating to housing and economic circumstances	0.000	0.995	0.005
S70.7 Multiple superficial injuries of hip and thigh	0.005	0.995	0.000
M48.02 Spinal stenosis (Cervical region)	0.005	0.995	0.000
Z60.9 Problem related to social environment, unspecified	0.000	0.995	0.005
M13.91 Arthritis, unspecified (Shoulder region)	0.005	0.995	0.000
S72.10 Pertrochanteric fracture (closed)	0.005	0.995	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
Z59.1 Inadequate housing	0.000	0.995	0.004
I08 Multiple valve diseases	0.000	0.995	0.005
S91.3 Open wound of other parts of foot	0.005	0.995	0.000
M48 Other spondylopathies	0.005	0.995	0.000
S72.80 Fractures of other parts of femur (closed)	0.004	0.995	0.000
S72.11 Pertrochanteric fracture (open)	0.004	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.995	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.000	0.995	0.005
S72.31 Fracture of shaft of femur (open)	0.004	0.995	0.000
S72.90 Fracture of femur, part unspecified (closed)	0.004	0.995	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
S72.81 Fractures of other parts of femur (open)	0.004	0.996	0.000
S78 Traumatic amputation of hip and thigh	0.004	0.996	0.000
S77 Crushing injury of hip and thigh	0.004	0.996	0.000
S75 Injury of blood vessels at hip and thigh level	0.004	0.996	0.000
S74 Injury of nerves at hip and thigh level	0.004	0.996	0.000
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.004	0.996	0.000
S72.91 Fracture of femur, part unspecified (open)	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
Z37.2 Twins, both liveborn	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T40.2 Other opioids	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
S72.71 Multiple fractures of femur (open)	0.004	0.996	0.000
S72.70 Multiple fractures of femur (closed)	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
S70.1 Contusion of thigh	0.004	0.996	0.000
T50.8 Diagnostic agents	0.004	0.996	0.000
S76 Injury of muscle and tendon at hip and thigh level	0.004	0.996	0.000
I87.8 Other specified disorders of veins	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
S72.4 Fracture of lower end of femur	0.004	0.996	0.000
S71 Open wound of hip and thigh	0.004	0.996	0.000
T40.5 Cocaine	0.004	0.996	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.001	0.996	0.003
T40.1 Heroin	0.004	0.996	0.000
T40.3 Methadone	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.004	0.996	0.000
S73.1 Sprain and strain of hip	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
R06.8 Other and unspecified abnormalities of breathing	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
S72.0 Fracture of neck of femur	0.004	0.996	0.000
M48.4 Fatigue fracture of vertebra	0.003	0.996	0.000
M48.3 Traumatic spondylopathy	0.003	0.996	0.000
M48.2 Kissing spine	0.003	0.996	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.003	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.996	0.000
I08.8 Other multiple valve diseases	0.000	0.996	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.996	0.000
T40.8 Lysergide [LSD]	0.003	0.996	0.000
T40.7 Cannabis (derivatives)	0.003	0.996	0.000
T40.0 Opium	0.003	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.996	0.000
T46.7 Peripheral vasodilators	0.003	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.996	0.000
T46.1 Calcium-channel blockers	0.003	0.996	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.996	0.003
S71.0 Open wound of hip	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
S79 Other and unspecified injuries of hip and thigh	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
S74.9 Injury of unspecified nerve at hip and thigh level	0.003	0.997	0.000
S74.8 Injury of other nerves at hip and thigh level	0.003	0.997	0.000
S74.7 Injury of multiple nerves at hip and thigh level	0.003	0.997	0.000
S74.2 Injury of cutaneous sensory nerve at hip and thigh level	0.003	0.997	0.000
S74.1 Injury of femoral nerve at hip and thigh level	0.003	0.997	0.000
S74.0 Injury of sciatic nerve at hip and thigh level	0.003	0.997	0.000
S75.9 Injury of unspecified blood vessel at hip and thigh level	0.003	0.997	0.000
S75.8 Injury of other blood vessels at hip and thigh level	0.003	0.997	0.000
S75.7 Injury of multiple blood vessels at hip and thigh level	0.003	0.997	0.000
S75.2 Injury of greater saphenous vein at hip and thigh level	0.003	0.997	0.000
S75.1 Injury of femoral vein at hip and thigh level	0.003	0.997	0.000
S75.0 Injury of femoral artery	0.003	0.997	0.000
S77.2 Crushing injury of hip with thigh	0.003	0.997	0.000
S77.1 Crushing injury of thigh	0.003	0.997	0.000
S77.0 Crushing injury of hip	0.003	0.997	0.000
S78.9 Traumatic amputation of hip and thigh, level unspecified	0.003	0.997	0.000
S78.1 Traumatic amputation at level between hip and knee	0.003	0.997	0.000
S78.0 Traumatic amputation at hip joint	0.003	0.997	0.000
I08.9 Multiple valve disease, unspecified	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
S76.3 Injury of muscle and tendon of the posterior muscle group at thigh level	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations